Venous Thromboembolism in Progress

June 2011
Mayo Clinic Proceedings;Jun2011, Vol. 86 Issue 6, p556
Academic Journal
Case Study
The article presents a case study of an old man with inferior infarction who was admitted to the hospital because of near-syncopal episode, sudden dyspnea and pleuritic chest pain. It mentions that right bundle-branch block and sinus tachycardia were revealed in initial electrocardiogram. It states that thrombolysis with unfractioned heparin infusion improved the symptoms of patient.


Related Articles

  • Early Definition of Treatment Outcomes After Reperfusion Therapy for Myocardial Infarction. Zhang, Yi; Patel, Anushka; Jeremy, Richmond W. // Heart, Lung & Circulation;Mar2004, Vol. 13 Issue 1, p31 

    Aims. Early definition of treatment outcomes, including coronary patency and infarct size, after reperfusion therapy for myocardial infarction (MI) is desirable to identify patients requiring further intervention.Methods and Results. Patients receiving reperfusion therapy for a first MI had...

  • Use of the Electrocardiograph-Based Thrombolytic Predictive Instrument To Assist Thrombolytic and Reperfusion Therapy for Acute Myocardial Infarction. Selker, Harry P.; Beshansky, Joni R.; Griffith, John L. // Annals of Internal Medicine;7/16/2002, Vol. 137 Issue 2, p87 

    Presents a study that tests whether the electrocardiogram-based Thrombolytic Predicative Instrument(TPI) improves use of thrombolytic and reperfusion therapy. Discusses details of the trial, number of patients, percentage receiving therapy; Results and conclusions of the study.

  • A successfully thrombolysed acute inferior myocardial infarction due to type A aortic dissection with lethal consequences: the importance of early cardiac echocardiography.  // Journal of Cardiothoracic Surgery;2011, Vol. 6 Issue 1, p101 

    The article presents the case of a 57-year-old woman inferior standard therapy elevation myocardial infarction (STEMI) thrombolysed with tenecteplase and followed by clinical and electrocardiographic evidence of successful reperfusion. The patient's symptoms were relieved, while the pre-existing...

  • ASPIRIN AFTER THROMBOLYSIS FOR MI. Seaton, Terry L. // Journal of Family Practice;Mar1997, Vol. 44 Issue 3, p249 

    The article examines the optimal method of preventing reinfarction and death in patients who receive a thrombolytic for the treatment of acute myocardial infarction. The study enrolled patients who were treated with anistreplase. Risks of reinfarction, cardiac death, cardiac events and bleeding...

  • Registro de Alteplasa en Síndromes Coronarios Agudos con elevación del ST (REALSICA). Iturbe Orbe, Mario; Jerjes-Sánchez Díaz, Carlos; García-Sosa, Anabel; García, Héctor; Reyes Cerezo, Esteban; Fernández, Dolores; Garza Ruiz, Ángel; Assad, Christian; Castillo, Francisco; González, Miguel; García, Jerónimo; Valadéz, Francisco; Chávez, Mario; Garza, Óscar // Archivos de Cardiología de México;jul-sep2008, Vol. 78 Issue 3, p255 

    Objective: The registry intends to establish the safety and security of one-hour 100 mg alteplase infusion and 50 mg in 30 minutes to facilitate percutaneous coronary intervention (PCI) in a cardiology hospital with primary angioplasty program (24 hours 365 days a year) with current doses of...

  • Heparin's value is uncertain after post-MI thrombolysis.  // Modern Medicine;Aug96, Vol. 64 Issue 8, p54 

    Presents an abstract of a research titled `Overview of Randomized Trials of Intravenous Heparin in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy,' by K.W. Mahaffey, C.B. Granger, R. Collins, et al, published in the March 15, 1996 issue of `American Journal of...

  • Adjuncts to Thrombolysis for Myocardial Reperfusion. Popma, Jeffrey J.; Topol, Eric J. // Annals of Internal Medicine;7/1/91, Vol. 115 Issue 1, p34 

    Discusses adjunctive pharmacologic agents for acute myocardial infarction. Pharmacologic adjuncts to thrombolysis for myocardial infarction; Adverse clinical outcomes associated with reocclusion in the thrombolysis and angioplasty in myocardial infarction trials; Adjunctive role of heparin in...

  • Thrombolysis, With or Without Heparin, During the First Nine Weeks After Acute Myocardial Infarction. Pickering, W.; Brozovic, M.; Dancy, M.; Cohen, H. // Clinical & Applied Thrombosis/Hemostasis;Jul1997, Vol. 3 Issue 3, p183 

    The duration and characteristics of fibrinolytic "shut-down" were studied in 40 patients serially for a 9-week period after acute myocardial infarction (AMI). Patients were randomized into four equal groups to receive streptokinase (SK). SK plus heparin (SK + H), recombinant tissue plasminogen...

  • Low frequency mechanical actuation accelerates reperfusion in-vitro. Marzencki, Marcin; Kajbafzadeh, Behrad; Khosrow-khavar, Farzad; Tavakolian, Kouhyar; Soleimani-Nouri, Maxim; Hamburger, Jaap; Kaminska, Bozena; Menon, Carlo // BioMedical Engineering OnLine;2013, Vol. 12 Issue 1, p2 

    Background Rapid restoration of vessel patency after acute myocardial infarction is key to reducing myocardial muscle death and increases survival rates. Standard therapies include thrombolysis and direct PTCA. Alternative or adjunctive emergency therapies that could be initiated by minimally...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics